Who owns Applied Therapeutics Inc?
- CUSIP Number: 03828a101
Tip: Access positions for across all investors
Analyze quarterly positions in Applied Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Applied Therapeutics stock
Who bought or sold Applied Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management | 21M | $13M | 15% | Sep 2025 |
|
| Vestal Point Capital | 14M | $8.6M | 24% | Sep 2025 |
|
| Propel Bio Management | 11M | $6.8M | 0% | Sep 2025 |
|
| Knoll Capital Management | 7.8M | $4.7M | 0% | Sep 2025 |
|
| Vanguard Group | 6.4M | $635k | 25% | Dec 2025 |
|
| Simplify Asset Management | 4.5M | $2.7M | 0% | Sep 2025 |
|
| Deltec Asset Management | 3.8M | $385k | 100% | Dec 2025 |
|
| BlackRock | 3.8M | $2.3M | -26% | Sep 2025 |
|
| Pathstone Holdings | 2.6M | $1.6M | 0% | Sep 2025 |
|
| Adage Capital Partners GP | 2.2M | $1.3M | 83% | Sep 2025 |
|
| Rock Springs Capital Management | 2.1M | $1.3M | 0% | Sep 2025 |
|
| Franklin Resources | 2.0M | $1.2M | 0% | Sep 2025 |
|
| Millennium Management | 1.9M | $1.2M | -2% | Sep 2025 |
|
| Geode Capital Management | 1.5M | $149k | 17% | Dec 2025 |
|
| Qube Research & Technologies | 1.2M | $706k | -36% | Sep 2025 |
|
| Hudson Bay Capital Management | 806k | $487k | 100% | Sep 2025 |
|
| UBS Group | 719k | $72k | -62% | Dec 2025 |
|
| Susquehanna International | 640k | $387k | 4% | Sep 2025 |
|
| Deutsche Bank Aktiengesellschaft | 622k | $380k | 0% | Sep 2025 |
|
| State Street Corporation | 519k | $314k | 47% | Sep 2025 |
|
| Rockefeller Capital Management | 392k | $237k | 100% | Sep 2025 |
|
| Marshall Wace | 337k | $34k | -87% | Dec 2025 |
|
| Hennion & Walsh Asset Management | 327k | $33k | 16% | Dec 2025 |
|
| Bank of New York Mellon | 254k | $25k | 219% | Dec 2025 |
|
| Citadel Advisors | 252k | $153k | -66% | Sep 2025 |
|
| Birchview Capital | 225k | $136k | -20% | Sep 2025 |
|
| Royal Bank of Canada | 203k | $0 | 15241% | Sep 2025 |
|
| Two Sigma Investments | 199k | $120k | -67% | Sep 2025 |
|
| Northern Trust | 174k | $105k | -1% | Sep 2025 |
|
| Squarepoint Ops | 159k | $96k | 1445% | Sep 2025 |
|
| Goldman Sachs Group | 146k | $15k | -6% | Dec 2025 |
|
| AQR Capital Management | 110k | $66k | -62% | Sep 2025 |
|
| Scientech Research | 105k | $64k | 100% | Sep 2025 |
|
| Change Path | 100k | $61k | -4% | Sep 2025 |
|
| Hrt Financial | 95k | $57k | 72% | Sep 2025 |
|
| Group One Trading | 75k | $46k | -34% | Sep 2025 |
|
| Roble, Belko & Company | 66k | $7.0k | 113% | Dec 2025 |
|
| Jane Street | 62k | $37k | 81% | Sep 2025 |
|
| Tudor Investment Corporation | 58k | $35k | 0% | Sep 2025 |
|
| Virtu Financial | 51k | $31k | 100% | Sep 2025 |
|
| Wolverine Trading | 51k | $31k | 100% | Sep 2025 |
|
| Sphera Funds Management | 50k | $30k | 0% | Sep 2025 |
|
| SG Americas Securities | 42k | $4.0k | 154% | Dec 2025 |
|
| CacheTech | 39k | $22k | 0% | Sep 2025 |
|
| Adams Wealth Management | 39k | $22k | 0% | Sep 2025 |
|
| Tower Research Capital | 34k | $21k | -5% | Sep 2025 |
|
| Point72 Asia | 33k | $20k | 100% | Sep 2025 |
|
| Ethic | 27k | $16k | -5% | Sep 2025 |
|
| XTX Topco | 24k | $14k | 100% | Sep 2025 |
|
| Diadema Partners | 19k | $12k | 100% | Sep 2025 |
|
| FMR | 18k | $11k | -2% | Sep 2025 |
|
| Cresset Asset Management | 17k | $10k | 100% | Sep 2025 |
|
| HPM Partners | 17k | $10k | -43% | Sep 2025 |
|
| JustInvest | 16k | $9.8k | 40% | Sep 2025 |
|
| Perennial Investment Advisors | 12k | $7.0k | 0% | Sep 2025 |
|
| Stratos Wealth Advisors | 11k | $6.4k | -13% | Sep 2025 |
|
| Jpmorgan Chase & Co | 7.6k | $4.6k | 100% | Sep 2025 |
|
| Barclays | 5.3k | $3.2k | -53% | Sep 2025 |
|
| Quest Partners | 4.7k | $466.100000 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 3.5k | $2.1k | -58% | Sep 2025 |
|
| Sunbelt Securities | 1.0k | $605.000000 | 0% | Sep 2025 |
|
| SBI Securities | 823.00 | $497.997300 | -92% | Sep 2025 |
|
| Rhumbline Advisers | 544.00 | $329.011200 | 0% | Sep 2025 |
|
| Parallel Advisors | 100.00 | $60.000000 | 100% | Sep 2025 |
|
| Federation des caisses Desjardins du Quebec | 84.00 | $50.996400 | 0% | Sep 2025 |
|
Who sold out of Applied Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Pnc Financial Services | Sep 2025 | 2.9M | $1.8M |
| Tang Capital Management | Jun 2025 | 2.4M | $755k |
| Charles Schwab Investment Management | Jun 2025 | 404k | $126k |
| Two Sigma Advisers | Jun 2025 | 304k | $95k |
| HighTower Advisors | Jun 2025 | 220k | $68k |
| Schonfeld Strategic Advisors | Jun 2025 | 197k | $61k |
| Jain Global | Jun 2025 | 85k | $26k |
| China Universal Asset Management | Sep 2025 | 25k | $15k |
| Cantor Fitzgerald, L. P. | Jun 2025 | 25k | $7.8k |
| Ieq Capital | Jun 2025 | 16k | $5.1k |
| Baader Bank | Jun 2025 | 14k | $2.6k |
| ExodusPoint Capital Management | Jun 2025 | 11k | $3.0k |
| Beaumont Capital Management | Sep 2025 | 10k | $6.3k |
| Jump Financial | Jun 2025 | 10k | $3.1k |
| Mirae Asset Global Investments | Sep 2025 | 5.6k | $3.4k |
| Wells Fargo & Company | Jun 2025 | 2.5k | $775.883400 |
| Capital Advisors | Sep 2025 | 2.4k | $1.0k |
| CWM | Sep 2025 | 376.00 | $0 |